X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15040) 15040
Book Review (5562) 5562
Publication (1057) 1057
Book / eBook (195) 195
Newsletter (155) 155
Book Chapter (90) 90
Conference Proceeding (66) 66
Newspaper Article (36) 36
Transcript (20) 20
Magazine Article (11) 11
Web Resource (11) 11
Streaming Video (6) 6
Dissertation (5) 5
Journal / eJournal (2) 2
Presentation (2) 2
Data Set (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14118) 14118
humans (13257) 13257
antineoplastic agents - therapeutic use (6071) 6071
oncology (5663) 5663
female (5612) 5612
cancer (5051) 5051
male (4833) 4833
animals (4783) 4783
middle aged (3575) 3575
chemotherapy (3256) 3256
aged (2928) 2928
adult (2815) 2815
immunotherapy (2802) 2802
antineoplastic agents - pharmacology (2520) 2520
treatment outcome (2503) 2503
antineoplastic combined chemotherapy protocols - therapeutic use (2421) 2421
care and treatment (2391) 2391
mice (2365) 2365
antineoplastic agents (2164) 2164
pharmacology & pharmacy (1917) 1917
hematology (1845) 1845
immunology (1706) 1706
antimitotic agents (1702) 1702
neoplasms - drug therapy (1673) 1673
tumors (1606) 1606
research (1601) 1601
therapy (1594) 1594
health aspects (1535) 1535
cell line, tumor (1490) 1490
antineoplastic agents - administration & dosage (1421) 1421
combined modality therapy (1410) 1410
prognosis (1401) 1401
antineoplastic agents - adverse effects (1390) 1390
antibodies, monoclonal - therapeutic use (1357) 1357
medicine & public health (1337) 1337
analysis (1336) 1336
drug therapy (1259) 1259
immunologic factors - therapeutic use (1257) 1257
apoptosis (1253) 1253
antineoplastic agents, immunological - therapeutic use (1183) 1183
metastasis (1093) 1093
melanoma (1053) 1053
aged, 80 and over (1014) 1014
clinical trials as topic (1005) 1005
expression (961) 961
survival (949) 949
abridged index medicus (871) 871
immunotherapy - methods (866) 866
neoplasms - immunology (839) 839
rituximab (804) 804
article (789) 789
cancer therapies (773) 773
medicine, research & experimental (757) 757
clinical trials (738) 738
cells (737) 737
hematology, oncology and palliative medicine (734) 734
t cells (730) 730
adolescent (710) 710
retrospective studies (706) 706
melanoma - drug therapy (703) 703
neoplasms - therapy (703) 703
neoplasm staging (700) 700
medicine (691) 691
adjuvants, immunologic - therapeutic use (688) 688
biochemistry & molecular biology (684) 684
breast cancer (681) 681
medical research (681) 681
disease-free survival (677) 677
cytotoxicity (674) 674
risk factors (664) 664
in-vitro (663) 663
apoptosis - drug effects (661) 661
dendritic cells (654) 654
child (645) 645
survival analysis (641) 641
cell biology (639) 639
lung neoplasms - drug therapy (639) 639
lymphocytes (633) 633
monoclonal antibodies (630) 630
cell proliferation - drug effects (628) 628
dose-response relationship, drug (625) 625
mice, inbred balb c (621) 621
cancer research (615) 615
in-vivo (612) 612
leukemia (612) 612
transplantation (609) 609
molecular targeted therapy (608) 608
breast neoplasms - drug therapy (607) 607
surgery (605) 605
skin neoplasms - drug therapy (585) 585
patients (584) 584
survival rate (575) 575
time factors (574) 574
proteins (573) 573
carcinoma (568) 568
antineoplastic combined chemotherapy protocols - adverse effects (561) 561
t-cells (561) 561
toxicity (559) 559
development and progression (549) 549
neoplasm metastasis (545) 545
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (139) 139
Online Resources - Online (14) 14
Collection Dvlpm't (Acquisitions) - Vendor file (12) 12
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
Chemistry (A D Allen) - Stacks (3) 3
Gerstein Science - Circulation Desk (2) 2
Credit Valley Hospital - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
East Asian (Cheng Yu Tung) - Reference (1) 1
Gerstein Science - Periodical Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15071) 15071
Russian (100) 100
German (82) 82
French (63) 63
Japanese (40) 40
Spanish (28) 28
Polish (27) 27
Italian (25) 25
Hungarian (15) 15
Danish (13) 13
Chinese (9) 9
Romanian (7) 7
Norwegian (4) 4
Czech (3) 3
Serbian (3) 3
Croatian (1) 1
Dutch (1) 1
Icelandic (1) 1
Portuguese (1) 1
Slovenian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 22, pp. 2078 - 2092
Journal Article
Annals of Oncology, ISSN 0923-7534, 2017, Volume 28, Issue 2, pp. 368 - 376
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10075, pp. 1195 - 1205
Summary Background Clinical trials have shown that trastuzumab, a recombinant monoclonal antibody against HER2 receptor, significantly improves overall... 
Internal Medicine | SYSTEM | MEDICINE, GENERAL & INTERNAL | MULTICENTER | PHASE-3 TRIAL | OPEN-LABEL | RANDOMIZED CONTROLLED-TRIAL | PERTUZUMAB | Antineoplastic Agents, Immunological - administration & dosage | Trastuzumab - therapeutic use | Drug Administration Schedule | Follow-Up Studies | Biomarkers, Tumor - analysis | Humans | Middle Aged | Kaplan-Meier Estimate | Trastuzumab - adverse effects | Treatment Outcome | Trastuzumab - administration & dosage | Breast Neoplasms - drug therapy | Antineoplastic Agents, Immunological - adverse effects | Breast Neoplasms - chemistry | Antineoplastic Agents, Immunological - therapeutic use | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Adult | Female | Aged | Receptor, ErbB-2 - analysis | Heart Diseases - chemically induced | Antimitotic agents | Medical colleges | Analysis | Adjuvant treatment | Monoclonal antibodies | Breast cancer | Antineoplastic agents | Cancer | Heart | Laboratories | Toxicity | Medical services | Clinical trials | Cancer therapies | Incidence | Motivation | Failure analysis | Surgery | Heart diseases | Recombinant | Medical research | Health risks | Mammography | Radiation therapy | Patients | Survival | ErbB-2 protein | Chemotherapy | Breast | Informed consent | Trastuzumab | Schedules | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2016, Volume 22, Issue 18, pp. 4585 - 4593
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2016, Volume 22, Issue 12, pp. 2908 - 2918
Journal Article
The Lancet Oncology, ISSN 1470-2045, 01/2018, Volume 19, Issue 1, pp. 51 - 64
Journal Article
Blood, ISSN 0006-4971, 01/2018, Volume 131, Issue 4, pp. 387 - 396
Journal Article
European Urology, ISSN 0302-2838, 2017, Volume 72, Issue 6, pp. 962 - 971
Journal Article
The Lancet Oncology, ISSN 1470-2045, 11/2018, Volume 19, Issue 11, pp. 1468 - 1479
Journal Article
Journal Article